ChromaCode Inc, based in Carlsbad, CA, is a leading provider of innovative genomic solutions that aim to improve health outcomes through access to critical biomarkers for patient management. Their breakthrough High-Definition PCR (HDPCR) multiplexing platform enables transformative genomic solutions, offering physicians and lab partners faster results for improved decision making and better outcomes.
With their easy-to-implement and cost-effective workflows, including reagent kits and cloud-based software, ChromaCode Inc is making a significant impact in the fields of oncology and genomics. Their HDPCR technology allows for unprecedented coverage of clinically relevant biomarkers, offering a simplified, high-margin alternative to traditional methods. By enhancing molecular profiling capabilities, ChromaCode Inc is empowering labs to bring multi-analyte, high-content assays for oncology and other genomic applications to the forefront of patient care.
Generated from the website